The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux

European Archives of Oto-Rhino-Laryngology

Volumn 266, Issue 2, 2009, Pages 243-251

  McGlashan, Julian A ^a   Johnstone, Lesley M ^b   Sykes, John ^b   Strugala, Vicki ^c   Dettmar, Peter W ^c  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b RECKITT BENCKISER   (United Kingdom)

^c Technostics Limited   (United Kingdom)

Author keywords

Alginates; Gastro oesophageal reflux; Laryngopharyngeal reflux; Larynx

Indexed keywords

ALGINIC ACID; GAVISCON;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EXTREMITY PAIN; FEMALE; FOLLOW UP; GASTRIC PH MONITORING; HEADACHE; HUMAN; LARYNGOPHARYNGEAL REFLUX; MALE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, ORAL; ADULT; ALGINATES; ALUMINUM HYDROXIDE; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; HYPOPHARYNX; LARYNGITIS; LARYNGOSCOPY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBSERVER VARIATION; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SILICIC ACID; SODIUM BICARBONATE; SUSPENSIONS; TREATMENT OUTCOME;

EID: 57649195088     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-008-0708-7     Document Type: Article

References (26)

1. MP Copper CF Smit LD Stanojcic PP Devriese PF Schouwenburg LM Mathus-Vliegen 2000 High incidence of laryngopharyngeal reflux in patients with head and neck cancer Laryngoscope 110 1007 1011 10.1097/00005537-200006000-00023
2. MY Chen DJ Ott BJ Casolo KM Moghazy JA Koufman 1998 Correlation of laryngeal and pharyngeal carcinomas and 24-hour pH monitoring of the esophagus and pharynx Otolaryngol Head Neck Surg 119 460 462 Medline
3. JA Koufman 1991 The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury Laryngoscope 101 1 78 Medline
4. SJ Ossakow G Elta T Colturi R Bogdasarian TT Nostrant 1987 Esophageal reflux and dysmotility as the basis for persistent cervical symptoms Ann Otol Rhinol Laryngol 96 387 392 Medline
5. JA Koufman MR Amin M Panetti 2000 Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders Otolaryngol Head Neck Surg 123 385 388 10.1067/mhn.2000.109935
6. PC Belafsky GN Postma JA Koufman 2002 Validity and reliability of the reflux symptom index (RSI) J Voice 16 274 277 10.1016/S0892-1997(02)00097-8
7. PC Belafsky GN Postma JA Koufman 2001 Laryngopharyngeal reflux symptoms improve before changes in physical findings Laryngoscope 111 979 981 10.1097/00005537-200106000-00009
8. PC Belafsky GN Postma JA Koufman 2001 The validity and reliability of the reflux finding score (RFS) Laryngoscope 111 1313 1317 10.1097/00005537- 200108000-00001
9. JE Richter DM Hicks 1997 Unresolved issues in gastroesophageal reflux-related ear, nose, and throat problems Am J Gastroenterol 92 2143 2144 Medline
10. GN Postma 2000 Ambulatory pH monitoring methodology Ann Otol Rhinol Laryngol Suppl 184 10 14 Medline
11. MF Vaezi PL Schroeder JE Richter 1997 Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring Am J Gastroenterol 92 825 829 Medline
12. LH Willems-Bloemer GC Vreeburg R Brummer 2000 Treatment of reflux-related and non-reflux-related dysphonia with profound gastric acid inhibition Folia Phoniatr Logop 52 289 294 10.1159/000021546
13. Freston JW (1997) Long-term acid control and proton pump inhibitors: interactions and safety issues in perspective. Am J Gastroenterol 92:51S-55S; discussion 55S-57S
14. FDA (2007) Early communication about an ongoing safety review: omeprazole (Prilosec), esomeprazole (Nexium)
15. JP Noordzij A Khidr BA Evans E Desper RK Mittal JF Reibel PA Levine 2001 Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study Laryngoscope 111 2147 2151 10.1097/00005537-200112000-00013
16. HB El-Serag P Lee A Buchner JM Inadomi M Gavin DM McCarthy 2001 Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial Am J Gastroenterol 96 979 983 10.1111/j.1572-0241.2001. 03681.x
17. CS Qua CH Wong K Gopala KL Goh 2007 Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy Aliment Pharmacol Ther 25 287 295 Medline
18. MF Vaezi JE Richter CR Stasney JR Spiegel RA Iannuzzi JA Crawley C Hwang MB Sostek R Shaker 2006 Treatment of chronic posterior laryngitis with esomeprazole Laryngoscope 116 254 260 10.1097/01.mlg.0000192173.00498.ba
19. JM Wo J Koopman SP Harrell K Parker W Winstead E Lentsch 2006 Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux Am J Gastroenterol 101 1972 1978 10.1111/j.1572-0241. 2006.00693.x
20. AJ Eherer W Habermann HF Hammer K Kiesler G Friedrich GJ Krejs 2003 Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study Scand J Gastroenterol 38 462 467 10.1080/00365520310001860
21. DL Steward KM Wilson DH Kelly MS Patil HR Schwartzbauer JD Long JA Welge 2004 Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial Otolaryngol Head Neck Surg 131 342 350 10.1016/j.otohns.2004.03.037
22. L Gatta D Vaira G Sorrenti S Zucchini C Sama N Vakil 2007 Meta-analysis: the efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro-oesophageal reflux disease Aliment Pharmacol Ther 25 385 392 Medline
23. TM Ours MS Kavuru RJ Schilz JE Richter 1999 A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough Am J Gastroenterol 94 3131 3138 10.1111/j.1572-0241.1999.01504.x
24. MF Vaezi DM Hicks TI Abelson JE Richter 2003 Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association Clin Gastroenterol Hepatol 1 333 344 10.1053/S1542-3565(03) 00177-0
25. J Tack 2006 Review article: the role of bile and pepsin in the pathophysiology and treatment of gastro-oesophageal reflux disease Aliment Pharmacol Ther 24 10 16 10.1111/j.1365-2036.2006.03070.x
26. N Washington 1990 Investigation into the barrier action of an alginate gastric reflux suppressant, Liquid Gaviscon Drug Invest 2 23 30